Cargando…

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

BACKGROUND: Many recent therapeutic interventions are necessary to improve the treatment of hepatocellular carcinoma (HCC), including immunotherapy, which seems to offer one of the new realistic therapeutic modalities. This study aims to investigate the optimization of immunotherapy for HCC patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabeen, Abdulwahab Ali, Abdel-Hamid, Fatma Farag, El-Houseini, Motawa Eisa, Fathy, Shadia Abdel-Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918270/ https://www.ncbi.nlm.nih.gov/pubmed/27508176 http://dx.doi.org/10.2147/JHC.S56012

Ejemplares similares

Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis
por: El-Houseini, Motawa Eisa, et al.
Publicado: (2017)

Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
por: Afifi, Ahmed M, et al.
Publicado: (2019)

Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients
por: Abdelaziz, Heba E., et al.
Publicado: (2022)

Serological Biomarkers of Hepatocellular Carcinoma in Egyptian Patients
por: El-Tayeh, Sarmad F., et al.
Publicado: (2012)

The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study
por: kotb, Raghda R., et al.
Publicado: (2023)

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Wang, Pengju, et al.
Publicado: (2017)

Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment
por: Wu, Chia-Jen, et al.
Publicado: (2018)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Wang, Pengju, et al.
Publicado: (2018)

Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013)

Interleukin-6 gene polymorphism in Saudi population with recurrent aphthous stomatitis
por: Shabana, Samah Jameel Saeed, et al.
Publicado: (2021)

Interleukin-8 Producing Hepatocellular Carcinoma with Pyrexia
por: Harimoto, Norifumi, et al.
Publicado: (2009)

Interleukin-4 and Interleukin-13 Gene Polymorphisms in Children With Idiopathic Nephrotic Syndrome
por: Al Rushood, Maysoun, et al.
Publicado: (2020)

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
por: Shen, Wanying, et al.
Publicado: (2022)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

Interleukin 39: a new member of interleukin 12 family
por: LU, ZHIYU, et al.
Publicado: (2020)

Contribution of interleukin 27 serum level to pathogenesis and prognosis in children with immune thrombocytopenia
por: Hassan, Tamer, et al.
Publicado: (2022)

Direct Relationship between Interleukin-10 Gene Polymorphism and Hepatocellular Carcinoma Complicated by Direct Acting Antiviral Treatment of Hepatitis C Virus
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2021)

Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis
por: Kovarik, Johannes J., et al.
Publicado: (2017)

Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway
por: Han, Xin, et al.
Publicado: (2023)

Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View
por: Nenu, Iuliana, et al.
Publicado: (2023)

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
por: Myojin, Yuta, et al.
Publicado: (2022)

Relevance of Serum Levels of Interleukin-6 and Syndecan-1 in Patients with Hepatocellular Carcinoma
por: Metwaly, Heba A., et al.
Publicado: (2012)

Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
por: Koh, Benjamin, et al.
Publicado: (2023)

Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
por: Gerosa, Franca, et al.
Publicado: (2008)

In vitro and in vivo studies of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles complex as an antitumor agent against hepatocellular carcinoma
por: Moawed, Fatma SM, et al.
Publicado: (2023)

Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo
Publicado: (1994)

Serum and Urine Interleukin-6 and Interleukin-8 Levels Do Not Differentiate Acute Pyelonephritis from Lower Urinary Tract Infections in Children
por: Al Rushood, Maysoun, et al.
Publicado: (2020)

Interleukin 1 beta and its association with the periodontal health of pregnant women
por: El Hassan, Nawal K.B., et al.
Publicado: (2023)

Role of Interleukin-2 in Uremic Pruritus Among Attendants of AL-Zahraa Hospital Dialysis Unit
por: Azim, Amira Adel Abdel, et al.
Publicado: (2015)

Interleukin-12 is not essential for silicosis in mice
por: Davis, Gerald S, et al.
Publicado: (2006)

Interleukin-12: A master regulator
por: Bashyam, Hema
Publicado: (2007)

Interleukin-12 family cytokines and sarcoidosis
por: Ringkowski, Sabine, et al.
Publicado: (2014)

Localized Interleukin-12 for Cancer Immunotherapy
por: Nguyen, Khue G., et al.
Publicado: (2020)

Association Between Interleukin-12 and Sarcopenia
por: Chen, Yuan-Yuei, et al.
Publicado: (2021)

Antitumor Activities of Interleukin-12 in Melanoma
por: Gao, Wei, et al.
Publicado: (2022)

Lack of Association between Interleukin 12 C(-1188)A Polymorphism and Irritable Bowel Syndrome
por: Barkhordari, Elham, et al.
Publicado: (2011)

Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma
por: Tak, Ki Hong, et al.
Publicado: (2018)

A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus
por: Omran, Mohamed M., et al.
Publicado: (2021)

Interleukin-35 Suppresses Interleukin-9-Secreting CD4(+) T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pkmgmtoeae7pia0obulm6v6krl